Isavuconazole: Phase III delayed

Basilea and partner Astellas will delay the restart of a halted, open-label, international Phase III trial evaluating

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE